COVID-19: For information related to COVID-19 (formerly referred to as “novel coronavirus"), visit massey.vcu.edu/covid-19

VCU Massey Cancer Center

Menu

Center news & funding

Massey researcher awarded $465,000 to investigate HPV, head and neck cancers

VCU Massey Cancer Center researcher Larisa Litovchick, M.D., Ph.D., was recently awarded $465,000 from the National Institute of Dental and Cranial Research to further investigate how human papillomavirus (HPV) leads to head and neck cancers. Findings may aid the development of novel targeted treatments.

Continue reading →

Illustration of a virus infecting a cancer cell

$2.3 million grant from the National Cancer Institute funds new viral-based gene therapies for lung cancer at Massey

Mutations in the p53 gene are found in more than half of all cancers, yet it has proven to be very difficult to target the gene with therapeutic drugs even 40 years after its discovery. VCU Massey Cancer Center researchers Sumitra Deb, Ph.D., and Brad Windle, Ph.D., are hoping to turn the tide with an innovative viral-based strategy, and they recently received more than $2 million from the National Cancer Institute to fund their work.

Continue reading →

Massey researcher elected to the International Statistical Institute

VCU Massey Cancer Center researcher Dipankar Bandyopadhyay, Ph.D., was recently elected as a member of the prestigious International Statistical Institute.

The International Statistical Institute (ISI) is a nonprofit organization founded in 1885 to promote the understanding, development and good practice of statistics worldwide. Elected membership is open to individuals who are established in their careers and have made noteworthy contributions to the statistical profession.

Continue reading →

An adult's and child's hands coming together to form a heart shape

$1.4m NCI grant will help develop promising new treatment for aggressive childhood cancer

VCU Massey Cancer Center researchers have been awarded a grant totaling more than $1.4 million over four years from the National Cancer Institute (NCI) to drive the development of a new treatment for MYCN-amplified neuroblastoma, an aggressive subset of pediatric nervous system cancer marked by overexpression of the MYCN gene. There are limited treatments currently available for MYCN-amplified neuroblastoma, and it is among the deadliest of the pediatric cancers.

Continue reading →

Steven Grant, M.D.

Massey awarded grant to collaborate with other elite cancer institutes on cutting-edge clinical trials

VCU Massey Cancer Center has received a UM1 sub-award from the National Cancer Institute to participate in the North American Star Consortium (NASC), an association of leading cancer institutes that collaborate on novel National Cancer Institute (NCI)-sponsored clinical trials featuring some of the most promising cancer therapies available.

Continue reading →